Editas Medicine

Editas Medicine

Clinical-stage genome editing company developing CRISPR-based medicines targeting genetic diseases of the eye, blood, and liver.

Industries Biotechnology and Digital Health
Regions North America
Tags crispr gene-editing ophthalmology rare-disease
HeadquartersCambridge, MA, USA
Founded2013
FounderDavid Liu, Jennifer Doudna, Feng Zhang, George Church, J. Keith Joung
Employees200–499
StockEDIT
OwnershipPublic
Geographic PresenceNorth America
HiringHiring
Innovation LevelHigh
Commercialisation StageClinical Stage
Africa PresenceYes
Websitewww.editasmedicine.com

Related Intelligence

×